Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Hum Reprod ; 32(3): 698-703, 2017 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-28122886

RESUMEN

We report on the first PGD performed for the m.14487 T>C mitochondrial DNA (mtDNA) mutation in the MT-ND6 gene, associated with Leigh syndrome. The female carrier gave birth to a healthy baby boy at age 42. This case adds to the successes of PGD for mtDNA mutations.


Asunto(s)
ADN Mitocondrial/genética , Enfermedad de Leigh/diagnóstico , Mutación , Femenino , Humanos , Recién Nacido , Enfermedad de Leigh/genética , Masculino , Mitocondrias/genética , Linaje , Embarazo , Diagnóstico Preimplantación , Resultado del Tratamiento
2.
J Med Genet ; 50(2): 125-32, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23339111

RESUMEN

BACKGROUND: Mitochondrial or oxidative phosphorylation diseases are relatively frequent, multisystem disorders; in about 15% of cases they are caused by maternally inherited mitochondrial DNA (mtDNA) mutations. Because of the possible severity of the phenotype, the lack of effective treatment, and the high recurrence risk for offspring of carrier females, couples wish to prevent the transmission of these mtDNA disorders to their offspring. Prenatal diagnosis is problematic for several reasons, and concern the often poor correlation between mutation percentages and disease severity and the uncertainties about the representativeness of a fetal sample. A new option for preventing transmission of mtDNA disorders is preimplantation genetic diagnosis (PGD), which circumvents these problems by transferring an embryo below the threshold of clinical expression. METHODS: We present the data on nine PGD cycles in four female carriers of mitochondrial diseases: three mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) (m.3243A>G), and one Leigh (m.8993T>G). Our threshold for transfer after PGD is 15% for the m.3243A>G mutation and 30% for the m.8993T>G mutation. RESULTS: All four female carriers produced embryos eligible for transfer. The m.8993T>G mutation in oocytes/embryos showed more skewing than the m.3243A>G. In about 80% of the embryos the mutation load in the individual blastomeres was fairly constant (interblastomere differences <10%). However, in around 11% (in embryos with the m.3243A>G mutation only), the mutation load differed substantially (>15%) between blastomeres of a single embryo, mostly as a result of one outlier. The m.8993T>G carrier became pregnant and gave birth to a healthy son. CONCLUSIONS: PGD provides carriers of mtDNA mutations the opportunity to conceive healthy offspring.


Asunto(s)
Análisis Mutacional de ADN/métodos , ADN Mitocondrial/análisis , Enfermedades Mitocondriales/diagnóstico , Enfermedades Mitocondriales/genética , Diagnóstico Preimplantación/métodos , Adulto , Blastómeros/fisiología , ADN Mitocondrial/química , ADN Mitocondrial/genética , Embrión de Mamíferos , Femenino , Humanos , Masculino , Mutación , Oocitos/fisiología , Linaje , Embarazo , Cigoto/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA